Literature DB >> 9860343

Cecal infarct: report of a case.

I Elnakadi1, A Mehdi, S Franck, T Roger, D Larsimont, J C Pector.   

Abstract

PURPOSE: The purpose of this article is to present a case of an uncommon opportunistic fungal infection that appears in immunologically or metabolically compromised patients and is usually fatal.
METHOD: A 54-year-old woman with an acute lymphoblastic leukemia had acute abdominal pain with peritoneal symptoms during her hospital stay. A laparotomy was performed and a cecal infarct firmly adherent to about 30 cm of infiltrated jejunal loop was discovered.
RESULTS: Microscopic studies revealed an infiltration of the jejunal wall by abnormal lymphocytes. The cecal and ileal walls were infiltrated by leukocytes. Blood vessels were invaded by giant cells and large, unseptated, right-angle branching hyphea.
CONCLUSIONS: These findings were considered typical of invasive mucormycosis of the cecum and the terminal ileum.

Entities:  

Mesh:

Year:  1998        PMID: 9860343     DOI: 10.1007/bf02237312

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

Review 1.  Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon's perspective.

Authors:  Oswens Siu-Hung Lo; Wai-Lun Law
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

2.  Invasive colonic mucormycosis in early induction therapy of childhood acute lymphoblastic leukemia.

Authors:  Boopathi Sellappan; Sameer Bakhshi; Rajni Safaya; Arun K Gupta; L S Arya
Journal:  Indian J Pediatr       Date:  2005-01       Impact factor: 1.967

3.  A rare cause of acute abdomen: Isolated necrosis of the cecum.

Authors:  Kemal Eyvaz; Hasan Ediz Sıkar; Mehmet Gökçeimam; Hasan Fehmi Küçük; Necmi Kurt
Journal:  Turk J Surg       Date:  2018-09-11

4.  Mucormycosis-induced ileocecal perforation: A case report and review of literature.

Authors:  R Poyuran; B S Dharan; S Sandhyamani; D Narasimhaiah
Journal:  J Postgrad Med       Date:  2020 Jan-Mar       Impact factor: 1.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.